Interferon-beta inhibits mitogen induced astrocyte proliferation in vitro

被引:29
|
作者
Malik, O
Compston, DAS
Scolding, NJ
机构
[1] Addenbrookes Hosp, Dept Neurol, Cambridge CB2 2QQ, England
[2] Univ Cambridge, MRC, Ctr Brain Repair, Cambridge CB2 2PY, England
基金
英国医学研究理事会;
关键词
multiple sclerosis; reactive astrocyte; growth factors; cytokines;
D O I
10.1016/S0165-5728(98)00049-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The central nervous system response to injury and inflammation commonly includes astrocytosis. This process, which is manifest by astrocyte hypertrophy and proliferation, is particularly prominent in multiple sclerosis (MS), where in chronic lesions it may contribute to the lack of repair by restricting the migration of remyelinating cells. Interferon-beta (IFN-beta) modestly reduces the frequency of relapses in MS and may have a small effect on the accumulation of permanent disability. Here, we show that IFN-P inhibits the in vitro proliferative response of rodent astrocytes to a wide variety of growth factors and cytokines. Although important species differences exist in these glial responses this previously unrecognised property of IFN-P may have implications for reducing astrocytosis and thereby promoting endogenous repair. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:155 / 162
页数:8
相关论文
共 50 条
  • [11] RECOMBINANT INTERFERON-BETA INHIBITS GAMMA-INTERFERON PRODUCTION IN MULTIPLE-SCLEROSIS
    PANITCH, HS
    FOLUS, JS
    JOHNSON, KP
    ANNALS OF NEUROLOGY, 1987, 22 (01) : 139 - 139
  • [12] APPLICATION OF INTERFERON-BETA IN VIRUS-INDUCED PAPILLOMAS
    NIIMURA, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 95 (06) : S149 - S151
  • [13] IN-VITRO EFFECTS OF INTERFERON-BETA ON HUMAN CNS CELLS
    YONG, VW
    ANTEL, JP
    WILLIAMS, K
    NEUROLOGY, 1994, 44 (04) : A212 - A212
  • [14] CHARACTERISTICS OF INVITRO ANTI-PROLIFERATION ACTIVITY OF HUMAN INTERFERON-BETA
    KATAOKA, T
    OHHASHI, F
    SAKURAI, Y
    IDA, N
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (02) : 75 - 80
  • [15] NEUTRALIZING INTERFERON-BETA ANTIBODIES IN MELANOMA PATIENTS TREATED WITH RECOMBINANT AND NATURAL INTERFERON-BETA
    FIERLBECK, G
    SCHREINER, T
    SCHABER, B
    WALSER, A
    RASSNER, G
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1994, 39 (04) : 263 - 268
  • [16] Immunomodulatory activity of interferon-beta
    Kasper, Lloyd H.
    Reder, Anthony T.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2014, 1 (08): : 622 - 631
  • [17] TACRINE AND HUMAN INTERFERON-BETA
    AHMAD, SR
    LANCET, 1993, 341 (8848): : 820 - 820
  • [18] INTERFERON-BETA FOR MALIGNANT GLIOMA
    CAIRNCROSS, JG
    MACDONALD, DR
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) : 672 - 672
  • [19] Migraine Intensification by Interferon-Beta
    Cantor, F. K.
    HEADACHE, 2011, 51 : 21 - 21
  • [20] Interaction of interferon-beta and irradiation
    Schmidberger, H
    Rave-Fränk, M
    Virsik-Peuckert, P
    Thürnau, K
    Thole, A
    Hess, CF
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S182 - S183